Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Julphar
Farmers Insurance
Argus Health
Medtronic
US Army
Covington
AstraZeneca
Federal Trade Commission

Generated: April 23, 2018

DrugPatentWatch Database Preview

ANTEPAR Drug Profile

« Back to Dashboard

Which patents cover Antepar, and when can generic versions of Antepar launch?

Antepar is a drug marketed by Glaxosmithkline and is included in one NDA.

The generic ingredient in ANTEPAR is piperazine citrate. There are eighteen drug master file entries for this compound. Additional details are available on the piperazine citrate profile page.
Drug patent expirations by year for ANTEPAR
Synonyms for ANTEPAR
2-hydroxypropane-1,2,3-tricarboxylic acid,piperazine,pentahydrate
2-hydroxypropane-1,2,3-tricarboxylic acid; piperazine
3C6H8O7.3C4H10N2.H2O
642.66 (anhydrous)
AC1L3FX5
AC1Q5SNX
ACMC-20ahp5
AK-47855
AKOS015920444
antepar hydrate
Anthecole
Antoban
ANW-73863
Ascarex Syrup
AX8148136
BR-47855
Bryrel
C12H30N6??C12H16O14??xH2O
C6H8O7.C4H10N2
CHEMBL1200842
Citric acid sesquipiperazine salt hydrate 250mg
CITRIC ACID; PIPERAZINE
CTK0H7247
DAK 63
Exelmin
Exopin
GS-3869
HE057177
HE342185
Helmezine
Helmizin
Jsp002598
KB-259286
KS-00000GXD
LS-111398
LS-174889
MolPort-023-221-326
MolPort-039-145-053
Multifuge citrate
Nemadital
NSC-203336
NSC-86779
NSC203336
NSC86779
Oxucide
Oxyzin (syrup)
Oxyzine
Oxyzine (syrup)
Parazine
Parazine citrate
Pin-Tega
Pinozan
Piperasol
Piperazine 2-hydroxypropane-1,2,3-tricarboxylate
Piperazine citrate
Piperazine citrate (3:2) hydrate
Piperazine Citrate (anhydrous)
Piperazine Citrate Telra
Piperazine Citrate USP
Piperazine compound with citric acid
Piperazine, 2-hydroxy-1,2,3-propanetricarboxylate (3:2), hydrate
Piperazine, citrate (3:2)
Piperazine,2,3-propanetricarboxylate (3:2)
Pipizan
Pipizan Citrate Syrup
Rhomex
RT-001192
S-7217
SC-22711
SCHEMBL125278
Ta-Verm
Vermago
Vermizine (elixir)
WLN: T6M DMTJ & 3 & 622 & QV1XQVQ1VQ & 2 & 621

US Patents and Regulatory Information for ANTEPAR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline ANTEPAR piperazine citrate SYRUP;ORAL 009102-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Glaxosmithkline ANTEPAR piperazine citrate TABLET;ORAL 009102-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Chubb
Deloitte
AstraZeneca
Cipla
McKesson
UBS
US Department of Justice
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.